| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.624 | 0.008 | 0.624 | 5 Hydroxytryptamine release inhibitor | 0.562 0.017 DBMET00011 | ||
| 0.549 | 0.016 | 0.549 | Histamine release inhibitor | 0.514 0.024 DBMET00011 | ||
| 0.522 | 0.001 | 0.522 | Angiotensin II receptor antagonist | 0.305 0.001 DBMET00011 | ||
| 0.439 | 0.001 | 0.439 | Angiotensin AT1 receptor antagonist | 0.229 0.001 DBMET00011 | ||
| 0.352 | 0.003 | 0.352 | Phosphodiesterase 7B inhibitor | 0.327 0.004 DBMET00011 | ||
| 0.312 | 0.005 | 0.312 | Alcohol dehydrogenase inhibitor | 0.255 0.007 DBMET00011 | ||
| 0.303 | 0.003 | 0.303 | AMPA 4 receptor antagonist | 0.063 0.009 DBMET00011 | ||
| 0.3 | 0.005 | 0.3 | Catenin beta inhibitor | 0.277 0.007 DBMET00011 | ||
| 0.272 | 0.002 | 0.272 | Angiotensin AT1A receptor antagonist | 0.191 0.002 DBMET00011 | ||
| 0.234 | 0.004 | 0.234 | Kainate receptor antagonist | 0.064 0.014 DBMET00011 | ||
| 0.268 | 0.039 | 0.268 | Growth hormone agonist | 0.247 0.044 DBMET00011 | ||
| 0.296 | 0.077 | 0.299 | Interleukin 2 agonist | 0.299 0.074 DBMET00011 | DBMET00011 | |
| 0.217 | 0.001 | 0.217 | Angiotensin AT1B receptor antagonist | 0.063 0.002 DBMET00011 | ||
| 0.222 | 0.026 | 0.222 | Hemostatic | 0.218 0.027 DBMET00011 | ||
| 0.197 | 0.003 | 0.197 | AMPA 3 receptor antagonist | 0.045 0.011 DBMET00011 | ||
| 0.179 | 0.003 | 0.179 | Angiotensin AT2 receptor antagonist | 0.138 0.003 DBMET00011 | ||
| 0.176 | 0.004 | 0.176 | Leukotriene D4 antagonist | 0.155 0.004 DBMET00011 | ||
| 0.165 | 0.003 | 0.165 | Kainate receptor 1 antagonist | 0.033 0.009 DBMET00011 | ||
| 0.19 | 0.041 | 0.19 | Neurotensin receptor agonist | |||
| 0.233 | 0.086 | 0.233 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.261 | 0.117 | 0.261 | Sodium/bile acid cotransporter inhibitor | 0.238 0.141 DBMET00011 | ||
| 0.153 | 0.015 | 0.153 | Phosphodiesterase 3A inhibitor | 0.109 0.027 DBMET00011 | ||
| 0.139 | 0.004 | 0.139 | AMPA 2 receptor antagonist | 0.088 0.006 DBMET00011 | ||
| 0.266 | 0.137 | 0.301 | Immunosuppressant | 0.301 0.114 DBMET00011 | DBMET00011 | |
| 0.129 | 0.005 | 0.129 | Bombesin 3 receptor antagonist | 0.114 0.008 DBMET00011 | ||
| 0.133 | 0.013 | 0.133 | Leukotriene antagonist | 0.112 0.017 DBMET00011 | ||
| 0.115 | 0.005 | 0.115 | AMPA 1 receptor antagonist | |||
| 0.113 | 0.004 | 0.113 | Kainate receptor 2 antagonist | |||
| 0.211 | 0.103 | 0.211 | Calpain inhibitor | |||
| 0.112 | 0.006 | 0.112 | Glutamate (mGluR group II) agonist | 0.078 0.009 DBMET00011 | ||
| 0.122 | 0.02 | 0.122 | Peroxisome proliferator-activated receptor gamma agonist | 0.119 0.02 DBMET00011 | ||
| 0.139 | 0.037 | 0.139 | Caspase 3 inhibitor | 0.122 0.057 DBMET00011 | ||
| 0.102 | 0.006 | 0.102 | Glutamate (mGluR2) agonist | 0.07 0.009 DBMET00011 | ||
| 0.115 | 0.029 | 0.115 | Glutamate receptor agonist | |||
| 0.09 | 0.007 | 0.09 | Nicotinic acid receptor 2 agonist | 0.053 0.013 DBMET00011 | ||
| 0.099 | 0.019 | 0.099 | Carbonic anhydrase stimulant | 0.054 0.047 DBMET00011 | ||
| 0.092 | 0.012 | 0.092 | Leukotriene B4 antagonist | 0.074 0.018 DBMET00011 | ||
| 0.082 | 0.009 | 0.082 | Carbonic anhydrase II stimulant | 0.07 0.014 DBMET00011 | ||
| 0.094 | 0.024 | 0.094 | Elastase 1 inhibitor | 0.077 0.038 DBMET00011 | ||
| 0.076 | 0.008 | 0.076 | Carbonic anhydrase I stimulant | 0.058 0.013 DBMET00011 | ||
| 0.079 | 0.014 | 0.079 | NMDA receptor subunit 3B antagonist | |||
| 0.11 | 0.046 | 0.11 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.134 | 0.076 | 0.135 | Neurotrophic factor | 0.135 0.074 DBMET00011 | DBMET00011 | |
| 0.079 | 0.024 | 0.079 | Caspase 9 inhibitor | 0.076 0.026 DBMET00011 | ||
| 0.105 | 0.052 | 0.105 | Falcipain inhibitor | |||
| 0.067 | 0.013 | 0.067 | Thymidylate synthase inhibitor | 0.042 0.039 DBMET00011 | ||
| 0.075 | 0.025 | 0.081 | Cathepsin E inhibitor | 0.081 0.022 DBMET00011 | DBMET00011 | |
| 0.101 | 0.051 | 0.101 | Falcipain 2 inhibitor | |||
| 0.109 | 0.062 | 0.109 | Falcipain 3 inhibitor | |||
| 0.068 | 0.021 | 0.075 | Endothelin-converting enzyme inhibitor | 0.075 0.019 DBMET00011 | DBMET00011 | |
| 0.064 | 0.018 | 0.071 | Immunoglobulin Fc receptor antagonist | 0.071 0.01 DBMET00011 | DBMET00011 | |
| 0.051 | 0.007 | 0.051 | Kainate receptor 4 antagonist | 0.03 0.014 DBMET00011 | ||
| 0.077 | 0.032 | 0.077 | Glutamate (mGluR) agonist | |||
| 0.063 | 0.023 | 0.063 | Leukotriene C antagonist | 0.054 0.049 DBMET00011 | ||
| 0.056 | 0.016 | 0.056 | Glutamate (mGluR4) antagonist | |||
| 0.07 | 0.033 | 0.092 | Prostaglandin F2 alpha antagonist | 0.092 0.015 DBMET00011 | DBMET00011 | |
| 0.066 | 0.031 | 0.066 | Human rhinovirus A protease inhibitor | 0.063 0.032 DBMET00011 | ||
| 0.048 | 0.015 | 0.048 | Glucagon-like peptide 1 receptor antagonist | 0.047 0.016 DBMET00011 | ||
| 0.049 | 0.016 | 0.049 | Glutamate (mGluR group II) antagonist | 0.035 0.03 DBMET00011 | ||
| 0.061 | 0.029 | 0.062 | Angiotensin-converting enzyme inhibitor | 0.062 0.028 DBMET00011 | DBMET00011 | |
| 0.045 | 0.013 | 0.045 | Caspase 2 inhibitor | 0.045 0.014 DBMET00011 | ||
| 0.04 | 0.009 | 0.04 | Neutral endopeptidase inhibitor | 0.033 0.011 DBMET00011 | ||
| 0.037 | 0.008 | 0.037 | Kainate receptor 5 antagonist | 0.019 0.016 DBMET00011 | ||
| 0.162 | 0.133 | 0.162 | Platelet antagonist | 0.155 0.139 DBMET00011 | ||
| 0.129 | 0.1 | 0.129 | Thrombolytic | |||
| 0.107 | 0.078 | 0.107 | Cell adhesion inhibitor | |||
| 0.054 | 0.027 | 0.054 | HCV NS3/NS4A protease inhibitor | |||
| 0.04 | 0.014 | 0.04 | Glucagon receptor antagonist | |||
| 0.112 | 0.086 | 0.112 | Cathepsin H inhibitor | |||
| 0.06 | 0.034 | 0.082 | Cathepsin D inhibitor | 0.082 0.024 DBMET00011 | DBMET00011 | |
| 0.031 | 0.008 | 0.031 | Leukotriene B4 receptor 2 antagonist | 0.03 0.009 DBMET00011 | ||
| 0.06 | 0.039 | 0.06 | Sphingosine kinase inhibitor | 0.056 0.048 DBMET00011 | ||
| 0.041 | 0.02 | 0.041 | Nicotinic acid receptor agonist | |||
| 0.054 | 0.035 | 0.054 | Acetyl-CoA transferase inhibitor | |||
| 0.034 | 0.015 | 0.034 | Leukotriene B4 receptor 1 antagonist | 0.029 0.018 DBMET00011 | ||
| 0.027 | 0.008 | 0.027 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.023 | 0.005 | 0.023 | Carbonic anhydrase IV stimulant | 0.017 0.008 DBMET00011 | ||
| 0.024 | 0.007 | 0.024 | Kainate receptor 3 antagonist | 0.016 0.014 DBMET00011 | ||
| 0.043 | 0.026 | 0.043 | Cathepsin L2 inhibitor | |||
| 0.04 | 0.023 | 0.04 | Leukotriene C4 antagonist | |||
| 0.034 | 0.018 | 0.034 | Peptide deformylase inhibitor | |||
| 0.108 | 0.092 | 0.108 | Toll-Like receptor 2 antagonist | |||
| 0.044 | 0.029 | 0.044 | Glutamate (mGluR group III) antagonist | |||
| 0.151 | 0.135 | 0.2 | Hypolipemic | 0.2 0.094 DBMET00011 | DBMET00011 | |
| 0.04 | 0.025 | 0.04 | NMDA receptor subunit 3A antagonist | |||
| 0.058 | 0.044 | 0.058 | Collagenase 3 inhibitor | |||
| 0.088 | 0.074 | 0.088 | Aminopeptidase B inhibitor | |||
| 0.047 | 0.034 | 0.047 | Bombesin antagonist | 0.047 0.035 DBMET00011 | ||
| 0.062 | 0.049 | 0.062 | Neutrophil collagenase inhibitor | |||
| 0.035 | 0.022 | 0.035 | Factor XI inhibitor | |||
| 0.038 | 0.026 | 0.038 | Cholecystokinin A antagonist | |||
| 0.043 | 0.032 | 0.044 | Phosphodiesterase 3B inhibitor | 0.044 0.031 DBMET00011 | DBMET00011 | |
| 0.052 | 0.042 | 0.052 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.088 | 0.079 | 0.088 | Bile acid receptor antagonist | |||
| 0.014 | 0.005 | 0.014 | Immunosuppressant Cyclosporine-like | 0.013 0.006 DBMET00011 | ||
| 0.02 | 0.012 | 0.02 | Caspase 8 inhibitor | |||
| 0.068 | 0.06 | 0.068 | Metalloproteinase-9 inhibitor | |||
| 0.039 | 0.032 | 0.039 | Neurokinin 2 agonist | |||
| 0.044 | 0.037 | 0.044 | AMPA receptor antagonist | |||
| 0.03 | 0.023 | 0.03 | CXC chemokine 3 receptor antagonist | |||
| 0.057 | 0.05 | 0.057 | NMDA 2C receptor antagonist | |||
| 0.059 | 0.053 | 0.066 | Phosphodiesterase III inhibitor | 0.066 0.047 DBMET00011 | DBMET00011 | |
| 0.043 | 0.037 | 0.043 | Farnesyltransferase inhibitor | |||
| 0.051 | 0.045 | 0.051 | Sphingosine kinase 2 inhibitor | |||
| 0.039 | 0.035 | 0.039 | Macrophage elastase inhibitor | 0.039 0.035 DBMET00011 | ||
| 0.096 | 0.093 | 0.099 | Electron transport complex I inhibitor | 0.099 0.086 DBMET00011 | DBMET00011 | |
| 0.058 | 0.057 | 0.058 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.022 | 0.024 | 0.023 | Prostaglandin EP4 antagonist | 0.023 0.021 DBMET00011 | DBMET00011 | |
| 0.079 | 0.086 | 0.102 | Protease inhibitor | 0.102 0.064 DBMET00011 | DBMET00011 | |
| 0.144 | 0.165 | 0.206 | Vasodilator | 0.206 0.1 DBMET00011 | DBMET00011 | |
| 0.031 | 0.054 | 0.041 | HIV-1 protease inhibitor | 0.041 0.033 DBMET00011 | DBMET00011 | |
| 0.052 | 0.086 | 0.066 | Aminopeptidase I inhibitor | 0.066 0.06 DBMET00011 | DBMET00011 | |
| 0.171 | 0.211 | 0.205 | Vasodilator, coronary | 0.205 0.177 DBMET00011 | DBMET00011 | |
| 0.13 | 0.175 | 0.179 | Immunostimulant | 0.179 0.133 DBMET00011 | DBMET00011 | |
| 0.052 | 0.099 | 0.069 | Secretase beta inhibitor | 0.069 0.051 DBMET00011 | DBMET00011 | |
| 0.046 | 0.432 | 0.148 | Insulin secretagoues | 0.148 0.077 DBMET00011 | DBMET00011 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |